CION Ameerpet
Immunotherapy Side Effects · Heart, Kidney, Muscle & Nerve Reactions
Immune Myocarditis — The Rare Heart Reaction That Must Not Be Missed
Immune myocarditis is a rare inflammation of the heart muscle caused by an overactive immune response during checkpoint-inhibitor immunotherapy. It affects a small proportion of patients, but it is among the most dangerous immune-related reactions because it can worsen from mild symptoms to a life-threatening emergency within hours. NCCN and ASCO guidance on immune-related adverse events treats any new chest symptom, palpitations or unexplained breathlessness in the early cycles of immunotherapy as a same-day cardiac emergency, never a symptom to watch and wait on.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Rare, but fast-moving — myocarditis affects only a small proportion of patients, but can worsen within hours once it starts.
- Usually appears early — most cases begin within the first one to three cycles of immunotherapy.
- Easy to miss — mild fatigue, breathlessness or a fluttering heartbeat are often mistaken for ordinary treatment tiredness.
- Go to the ER for red flags — chest pain, fainting or a racing, irregular heartbeat need emergency care immediately.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Symptom triage
How Urgent Are Symptoms of Immune Myocarditis?
Immune myocarditis is rare, but it carries one of the highest fatality rates of any immune-related reaction if it goes unrecognised, because it can move from mild breathlessness to a dangerous heart rhythm or heart failure within hours to a few days. Any new chest pain, palpitations, unexplained breathlessness or fainting during immunotherapy — especially in the first few cycles — needs emergency assessment, not a wait-and-see approach.
Go to the ER now, or call an ambulance, if you have any of these:
- Chest pain or a feeling of pressure or tightness in the chest
- Palpitations, or a racing or irregular heartbeat
- Breathlessness at rest, or fainting
- Severe new fatigue with swelling in the ankles or legs
For any other new heart-related symptom during immunotherapy, call the CION helpline the same day:
Call the CION Helpline Now: 1800 202 8726
Know the difference
What Are the Early Signs of Immune Myocarditis?
The earliest signs are often mild and easy to mistake for ordinary treatment fatigue — new tiredness beyond your usual pattern, breathlessness with light activity, a fluttering or racing heartbeat, or mild swelling in the ankles. These signs are easy to dismiss, which is exactly why any new cardiac-type symptom in the early cycles of immunotherapy is checked with an ECG and a blood troponin test rather than assumed to be tiredness.
| Feature | Everyday tiredness or breathlessness (exertion, heat, anxiety) | Possible immune myocarditis — needs emergency review |
|---|---|---|
| Onset | Comes on with clear exertion and settles with rest | New or worsening over hours to days, even at rest |
| Heartbeat | Normal, or brief flutter that passes quickly | Persistent racing, irregular or pounding heartbeat |
| Chest sensation | Absent | Pain, pressure or tightness |
| Swelling | Rare, mild if present | New swelling in the ankles or legs |
| Response to rest | Improves within minutes | Little or no improvement |
Timing matters
How Soon After Starting Immunotherapy Does Myocarditis Appear?
Immune myocarditis most often develops within the first one to three cycles of checkpoint-inhibitor immunotherapy — typically the first six to twelve weeks of treatment — though it can occur at any point, including after just a single dose. This early, unpredictable timing is why any new chest or heart-related symptom in the early cycles is reported the same day it appears, not tracked for a few days to see if it settles.
| Stage | What's typically happening |
|---|---|
| Typically starts | Most often within the first 1–3 cycles (roughly the first 6–12 weeks) of checkpoint-inhibitor immunotherapy — though it can occur at any point, including after a single dose. |
| Early phase | Mild fatigue, breathlessness on exertion, or a fluttering heartbeat — easy to mistake for general treatment tiredness. |
| If unreported | Can progress to chest pain, a dangerous heart rhythm, or heart failure within hours to a few days. |
There is no safe home-management step for chest pain, palpitations or unexplained breathlessness during immunotherapy — myocarditis and other rare, severe reactions in this cluster are grouped together for exactly this reason. The correct response is always the same: get it checked immediately, or go to the ER for the emergency signs above.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Don't Wait Out a Heart Symptom on Immunotherapy
Our tumour board includes the same specialists managing your immunotherapy — reach them directly.
What comes after you call
How Immune Myocarditis Is Diagnosed and Treated
Reporting a new chest or heart symptom early leads to a structured emergency pathway, not guesswork — a heart attack and other causes are ruled out alongside myocarditis, and treatment starts promptly once confirmed.
- 1
Emergency ECG and troponin blood test
Your team checks your heart rhythm and a blood marker of heart muscle injury (troponin) immediately, alongside oxygen and blood pressure monitoring.
- 2
Cardiology referral, without delay
A cardiologist is brought in urgently, working alongside your oncology team — immune myocarditis is managed jointly, not by oncology alone.
- 3
Echocardiogram or cardiac MRI
Imaging of the heart confirms the diagnosis, shows how much the heart muscle is affected, and rules out a heart attack or other cardiac causes.
- 4
High-dose steroids and immunosuppression
Treatment usually starts with high-dose steroids; more severe cases may need additional immune-suppressing medication under close cardiac monitoring.
- 5
Decision on immunotherapy
Because of the risk of recurrence, most tumour boards recommend permanently stopping the immunotherapy responsible once myocarditis is confirmed, and discuss what this means for your overall treatment plan.
Care during treatment
Rare Reactions Are Manageable When Caught Early
Patients who report chest or heart symptoms immediately are supported by the same multidisciplinary team throughout treatment.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Immune Myocarditis: Your Questions Answered
What are the early signs of immune myocarditis?
The earliest signs are often mild and easy to mistake for ordinary treatment fatigue — new tiredness beyond your usual pattern, breathlessness with light activity, a fluttering or racing heartbeat, or mild swelling in the ankles. Some patients notice these alongside muscle weakness or eyelid drooping, since immune myocarditis can occur together with other rare neuromuscular reactions. Because these signs overlap so closely with normal treatment side effects, any new cardiac-type symptom in the first few cycles of immunotherapy is checked with an ECG and a blood troponin test rather than assumed to be tiredness.
How soon after starting immunotherapy can myocarditis develop?
Immune myocarditis most often develops within the first one to three cycles of checkpoint-inhibitor immunotherapy — typically the first six to twelve weeks of treatment — though it can occur at any point, including after just a single dose. This early, unpredictable timing is why oncology teams treat any new chest or heart-related symptom during the early cycles with particular urgency, checking it the same day rather than waiting to see if it settles.
Why is immune myocarditis considered so dangerous?
Immune myocarditis is rare, but it carries one of the highest fatality rates of any immune-related reaction because it can progress from mild breathlessness to a dangerous heart rhythm or heart failure within hours to a few days. Unlike many other immune reactions, there is often little time between the first symptom and a life-threatening complication, which is why guidance from NCCN and ASCO treats any suspected case as a same-day cardiology emergency rather than something to monitor at home.
How urgent is chest pain or palpitations during immunotherapy?
Always urgent. Chest pain, palpitations, a racing or irregular heartbeat, breathlessness at rest, or fainting during immunotherapy should be treated as a possible cardiac emergency — go to the nearest emergency room or call an ambulance immediately, and mention that you are on immunotherapy so the team can check for immune myocarditis alongside a standard cardiac work-up.
Is immune myocarditis the same as a heart attack?
No, though the two can look similar and are checked for together. A heart attack is caused by a blocked blood vessel starving part of the heart muscle of oxygen; immune myocarditis is inflammation of the heart muscle caused by your own immune system reacting during checkpoint-inhibitor immunotherapy. Both need emergency evaluation with an ECG, blood troponin test and cardiology input, since the initial symptoms — chest pain, breathlessness, palpitations — can be identical.
Will myocarditis mean immunotherapy has to be stopped permanently?
Often, yes. Because immune myocarditis can be life-threatening, most oncology teams permanently stop the immunotherapy responsible once it is confirmed, rather than pausing and restarting as with milder reactions. Treatment typically includes high-dose steroids and, in more severe cases, additional immunosuppression under a cardiologist's care. Your tumour board discusses what this means for your overall cancer treatment plan and whether an alternative approach is appropriate.